// App-Quantinova.ai

1171 : Platelet-Targeted, Thrombin-Activatable Fibrinolytic Pro-Drugs As Novel Therapies: Application to the Prothrombotic Disorder of Heparin-Induced Thrombocytopenia (HIT)

Researchers

Presenter

  • Hyun Sook Ahn

Principal Investigators

  • Vincent M. Hayes

  • Mortimer Poncz

  • Sergei Zaitsev

  • Valerie Tutwiler

  • Yuhuan Wang

  • Daniel W. Bougie

  • M. Anna Kowalska

  • Lubica Rauova

  • Richard H. Aster

  • Douglas B. Cines

  • Vladimir R Muzykantov

Medical Centers

  • Department of Pathology, The Children's Hospital of Philadelphia, Philadelphia, PA

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

  • Blood/haematological Diseases

  • Pulmonary/Respiratory Diseases

Disease

  • Thrombocytopenia

  • Venous thrombosis

Biomarkers

  • Platelet Factor 4

Drug/Treatment

  • Adenosine

  • Adenosine Intravenous

  • Evithrom

  • Heparin

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved